Colleagues Laud 1994 Nobelists As Overdue For Coveted Prize

Colleagues Laud 1994 Nobelists As Overdue For Coveted Prize Author: Edward R. Silverman Date: November 28, 1994 Colleagues of the recently announced winners of the 1994 Nobel Prizes in chemistry, physics, and medicine or physiology, in praising the decisions of the Nobel committee, say the coveted Swedish honor is long overdue for each of this year's recipients. For their part, the winners are using their newfound re

Written byEdward Silverman
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Colleagues of the recently announced winners of the 1994 Nobel Prizes in chemistry, physics, and medicine or physiology, in praising the decisions of the Nobel committee, say the coveted Swedish honor is long overdue for each of this year's recipients. For their part, the winners are using their newfound recognition to lobby for greater funding for basic science.

Alfred G. Gilman, chairman of the pharmacology department at the University of Texas Southwestern Medical Center at Dallas, and Martin Rodbell, a scientist emeritus in the Laboratory of Cellular and Molecular Pharmacology at the National Institute of Environmental Health Sciences in Research Triangle Park, N.C., were named to share the prize in physiology or medicine for their discovery of G proteins and the role of these proteins in signal transduction.

George A. Olah, director of the Loker Hydrocarbon Research Institute at the University of Southern California (USC) in Los Angeles, was selected ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies